 AZD2014 is being studied in patients with various cancers as a single agent a drug that is used alone to treat the cancer or in combination with a number of anticancer therapies. Previous studies have also allowed investigators to determine the best dose and frequency of AZD2014 to achieve anti-tumor effects while reducing the likelihood of side effects. 